Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Czerepak Elizabeth

SEC-identified person · CIK 1263500 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Delcath Systems, INC. DTCH Director filed 2020 - 2026
Transcode Therapeutics, Inc. RNAZ Director filed 2025 - 2025
Vickers Vantage Corp. I VCKAU See Remarks filed 2022 - 2023
Sorrento Therapeutics, Inc. SRNEQ Director · EVP & Chief Financial Officer filed 2021 - 2022
Spectrum Pharmaceuticals INC SPPI Director filed 2019 - 2020
Pharmathene, INC PIP Director · See Remarks filed 2007 - 2017
Vyant Bio, Inc. VYNT Chief Financial Officer filed 2013 - 2013
Affymax INC AFFY Director filed 2006 - 2007

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.